2021
Patient Risk Factors Associated With 30- and 90-Day Readmission After Ventriculoperitoneal Shunt Placement for Idiopathic Normal Pressure Hydrocephalus in Elderly Patients: A Nationwide Readmission Study
Koo AB, Elsamadicy AA, Lin IH, David WB, Reeves BC, Santarosa C, Cord B, Malhotra A, Kahle KT, Matouk CC. Patient Risk Factors Associated With 30- and 90-Day Readmission After Ventriculoperitoneal Shunt Placement for Idiopathic Normal Pressure Hydrocephalus in Elderly Patients: A Nationwide Readmission Study. World Neurosurgery 2021, 152: e23-e31. PMID: 33862298, DOI: 10.1016/j.wneu.2021.04.010.Peer-Reviewed Original ResearchConceptsIdiopathic normal pressure hydrocephalusVP shunt surgeryShunt surgeryElderly patientsNormal pressure hydrocephalusPressure hydrocephalusNationwide Readmissions DatabaseVentriculoperitoneal shunt surgeryPatient risk factorsVentriculoperitoneal shunt placementQuality of careMultivariate regression analysisIndex admissionUnplanned readmissionReadmission ratesRenal failureMechanical complicationsPostoperative infectionShunt placementNinth RevisionFemale sexRisk factorsSubdural hemorrhageClinical ModificationReadmission
2020
Patient Risk Factors Associated with 30- and 90- Day Readmission after Ventriculoperitoneal Shunt Placement for Idiopathic Normal Pressure Hydrocephalus in Elderly Patients
Koo A, Elsamadicy A, Lin I, David W, Reeves B, Santarosa C, Cord B, Malhotra A, Kahle K, Matouk C. Patient Risk Factors Associated with 30- and 90- Day Readmission after Ventriculoperitoneal Shunt Placement for Idiopathic Normal Pressure Hydrocephalus in Elderly Patients. Neurosurgery 2020, 67 DOI: 10.1093/neuros/nyaa447_202.Peer-Reviewed Original Research
2019
Differences in 30- and 90-Day Readmission Rates After Surgical Treatment for Lumbar Degenerative Disc Disease in Elderly Patients (³ð65 Years): A National Readmission Database Study
Elsamadicy A, Koo A, Lee M, Kundishora A, Camara-Quintana J, Qureshi T, Kolb L, Laurans M, Abbed K. Differences in 30- and 90-Day Readmission Rates After Surgical Treatment for Lumbar Degenerative Disc Disease in Elderly Patients (³ð65 Years): A National Readmission Database Study. Neurosurgery 2019, 66: 310-629. DOI: 10.1093/neuros/nyz310_629.Peer-Reviewed Original Research